Cargando…
Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agent
Mitoxantrone is an anti-cancer agent used in the treatment of breast and prostate cancers. It is classified as a topoisomerase II poison, however can also be activated by formaldehyde to generate drug–DNA adducts. Despite identification of this novel form of mitoxantrone–DNA interaction, excessively...
Autores principales: | Evison, Ben J., Mansour, Oula C., Menta, Ernesto, Phillips, Don R., Cutts, Suzanne M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1920253/ https://www.ncbi.nlm.nih.gov/pubmed/17483512 http://dx.doi.org/10.1093/nar/gkm285 |
Ejemplares similares
-
CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity
por: Evison, Benny J., et al.
Publicado: (2009) -
Pixantrone beyond monotherapy: a review
por: Barrenetxea Lekue, Cristina, et al.
Publicado: (2019) -
Pixantrone Sensitizes Gram-Negative Pathogens to Rifampin
por: She, Pengfei, et al.
Publicado: (2022) -
Organocatalytic Removal of Formaldehyde Adducts from RNA and DNA Bases
por: Karmakar, Saswata, et al.
Publicado: (2015) -
Evidence that endogenous formaldehyde produces immunogenic and atherogenic adduct epitopes
por: Nakamura, Jun, et al.
Publicado: (2017)